Dual ISH and IHC

Human lung cancer with human PPIB positive control mRNA probe in red, CAM5.2 acidic cytokeratin immunohistochemical staining in green with DAPI as counterstain.

Human lung cancer with human PPIB positive control mRNA probe in red, CAM5.2 acidic cytokeratin immunohistochemical staining in green with DAPI as counterstain.

Dual ISH-IHC - Detection of OLFM4 using RNAscope technology and Lyzozyme using IHC

Dual ISH-IHC - Detection of OLFM4 using RNAscope technology and Lyzozyme using IHC

Dual ISH-IHC. Detection of alpha-smooth muscle actin (SMA) using IHC (green) and Olfr558 using RNAscope technology (red)

Dual ISH-IHC. Detection of alpha-smooth muscle actin (SMA) using IHC (green) and Olfr558 using RNAscope technology (red)

NEW! Introducing our protease-free pretreatment workflow for sequential RNA-Protein detection

 

Analysis of both RNA and protein provides invaluable information for understanding the regulation of expression. Both ISH and IHC technologies share common features that make them unique amongst the protein and RNA detection technologies.

    - Morphological context: detection of RNA and protein while conserving the cell and tissue structural integrity

    - Similar workflows from sample fixation, pre-treatment, hybridization, signal amplification and data analysis.

For labs that require high throughput and automated RNA in situ hybridization (ISH) analysis, ACD has partnered with Leica Biosystems and Roche Tissue Diagnostics, Inc to deliver RNAscope™ ISH automated assays. Both automated stainers offering the possibility to combine in situ hybridization and immunohistochemistry on the same slide.

Due to the multiple benefits of running both ISH and IHC and the robustness of the RNAscope assay, some customers developed a dual ISH-IHC protocol to combine both assays on the same sample slide. We conducted an interview with 4 researchers who developed their own dual ISH-IHC method to provide you some insights into their protocol.

Download the interview and learn from these experts how to develop a dual ISH-IHC protocol.

Interview with:

  • Kristie Wetzel, Novartis Institute for

    BioMedical Research, Cambridge, MA, USA.

  • Dr Bradley Spencer-Dene, The Francis Crick

    Institute, London, UK.

  • Wanda Wang, University of Pittsburgh, PA,

    USA.

  • Mike Millar, Queen’s Medical Research

    Institute, University of Edinburgh,

    Edinburgh, UK.

Recorded Webinar

Application of combined RNA in situ hybridization and multiplex immunohistochemistry to unravel tumor heterogeneity in prostate cancer.
Presented by Dr Nallasivam Palanisamy and Dr Courtney Anderson

Watch Webinar

ISH-IHC App Note

Learn more in our RNAscope ISH-IHC Application note.

Fill out the form below to download the application note:

Related Publications

Download our latest Dual ISH-IHC publication list with more than 300 publications.

Download Publication list

Related Protocol

Download our RNAscope LS Multiplex Fluorescent Assay Combined with Immunofluorescence Technical Note.

Download Technical Note

Download our RNAscope Multiplex Fluorescent Assay Combined with Immunofluorescence Technical Note

Download Technical Note

Download our RNAscope RED Assay and Immunofluorescence Technical Note

Download Technical Note

 

X
Contact Us

Complete one of the three forms below and we will get back to you.

For Quote Requests, please provide more details in the Contact Sales form below

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

Advanced Cell Diagnostics China

20F, Tower 3,
Raffles City Changning Office,
1193 Changning Road, Shanghai 200051

021-52293200
info.cn@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com